Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Search
Filing date Form Description View
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031954.pdf
0001104659-15-031954.rtf
0001104659-15-031954.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031951.pdf
0001104659-15-031951.rtf
0001104659-15-031951.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031952.pdf
0001104659-15-031952.rtf
0001104659-15-031952.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-049338.pdf
0001104659-15-049338.rtf
0001104659-15-049338.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-060960.pdf
0001104659-15-060960.rtf
0001104659-15-060960.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001179110-16-017730.pdf
0001179110-16-017730.rtf
0001179110-16-017730.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001179110-16-018638.pdf
0001179110-16-018638.rtf
0001179110-16-018638.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001179110-16-023125.pdf
0001179110-16-023125.rtf
0001179110-16-023125.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001179110-16-029537.pdf
0001179110-16-029537.rtf
0001179110-16-029537.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001179110-16-032094.pdf
0001179110-16-032094.rtf
0001179110-16-032094.xls